INSIGHTS
October 11, 2021

Digital health’s Walk of Fame

Digital health is ready to roll out the red carpet. We’ve grown up, cracked $20B, and now, even celebrities are taking notice, with several household names recently investing in digital health companies. Justin Bieber had “Baby” on the brain and invested in digital male fertility startup Legacy, along with famous friends The Weeknd, Orlando Bloom, and DJ Khaled. Pediatric behavioral health startup Elemy closed on $219M from funders including Ashton Kutcher and Chelsea Clinton. MindMaze, a Swiss virtual reality company addressing traumatic brain injuries, raised $125M from Leonardo DiCaprio-backed AlbaCore Capital at a $1.5B valuation. Oprah Winfrey participated in Maven Clinic’s mega deal in August, joining Reese Witherspoon, Mindy Kaling, and Natalie Portman from previous rounds. Serena Williams also got in on the action this summer with an investment in HUED, a platform that provides culturally sensitive care to Black and Latinx patients. And let’s not forget, Matthew McConaughey said “alright alright alright” to Unite Us’ social care solution earlier this spring. In our once-niche industry, we’re excited for the next season of financing from the stars.

Headlines

Pulse Check: An Analysis Of The FDA’s List Of AI- And ML-Enabled Devices
Insights gleaned from the FDA’s new database Rock Health

Major Health Systems Announce Digital Transformation Company
New nonprofit Graphite Health will build a data platform, marketplace, and more ierce Healthcare

FDA's Real-World Evidence Push Hampered By Data Challenges
Solving for “not all data is created equal” Healthcare Dive

CVS Health Plans To Turn Hundreds Of Stores Into Super-Clinics
Primary care providers on every street corner Fortune

Patient Advocates Are Increasingly Shaping Health Technology
Patients personally impacted by negative EHR experiences take a stand Insider

How Morgan Health Hopes To Finally Move The Needle On Employer Health Costs
A plan to avoid the missteps of Haven Healthcare Dive

The Economic Value Of Targeting Aging
“A slowdown in aging that increases life expectancy by 1 year is worth $38T nationally” Nature

Recent Funding